Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAXITAMAB-GQGK: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

53.4%
Female
46.6%
Male

Age Information

The average age of patients reporting adverse events with NAXITAMAB-GQGK is 7.5 years.

Geographic Distribution

The majority of adverse event reports for NAXITAMAB-GQGK originate from US.

Report Summary & Outcomes

152
Total Reports
152
As Primary/Secondary Suspect
2
Deaths Reported
56
Hospitalizations
17
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 20200101. Most recent report: 20250715. View full timeline →

More About NAXITAMAB-GQGK

NAXITAMAB-GQGK Full Profile Reports by Year Drug Interactions